CX 2026: Venous and lymphatic session highlights continued innovation following recent PE trials
“Are we at the end of the road with this technology?” asked attendees of yesterday’s opening venous and lymphatic session at the 2026 Charing...
Gore Viabahn Fortegra study reports favourable patency and symptom improvement in iliocaval obstruction
Twelve-month primary results from the Gore Viabahn Fortegra prospective, multicentre trial evaluating a novel venous stent system suggest endovascular treatment of symptomatic iliocaval obstruction...
C-TRACT trial results hail “new era” for post-thrombotic syndrome following DVT
“These patients have suffered in silence because few physicians are aware of this complication or know how to effectively treat it,” said Suresh Vedantham...
US FDA warns thousands of companies and researchers against suppressing unfavourable trial results
The US Food and Drug Administration (FDA) has reminded more than 2,200 medical product companies and researchers of requirements for them to submit certain...
